Claroty vs Cylera (2026)
Both discover connected devices on hospital networks. Claroty sells xDome for Healthcare, built on Medigate, which Claroty bought in 2022. It profiles each device, ranks vulnerabilities by clinical impact, designs segmentation and manages vendor remote access. Claire, an AI agent launched in May 2026, triages alerts, drafts policy and opens tickets. Cylera collects device data passively, without agents. It builds virtual copies of devices from their traffic and runs vulnerability tests against those instead of the live equipment. A policy generator writes segmentation rules and enrolls new devices automatically. Choose Claroty for published certificates, a business associate statement and vendor remote access; choose Cylera to test vulnerabilities on emulated copies of devices.
- Vulnerabilities should be ranked by their clinical impact.
- Device manufacturers' remote access should be managed in the same platform.
- Your security review needs downloadable certificates and a stated business associate position.
- Vulnerability tests should run on emulated devices, not live ones.
- New devices should be enrolled into segmentation policy automatically.
- You report against the NHS Data Security and Protection Toolkit as well as US rules.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Claroty and Cylera are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Claroty | Cylera |
|---|---|---|
| Primary category | Healthcare Cybersecurity | Healthcare Cybersecurity |
| Founded | 2015 | Not recorded |
| Headquarters | New York, New York, United States | New York, New York, United States |
| Website | claroty.com | cylera.com |
Side by Side
Select any grade to read the note behind it.
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Claroty sells cyber-physical systems security to hospitals, industry, commercial buildings and government, and its healthcare product is Claroty xDome for Healthcare, built on Medigate, which Claroty acquired in 2022.
Source: AI Health Index, September 2026
Cylera sells an IoT asset intelligence and security platform that began in hospitals and now also serves finance, higher education, transportation, manufacturing and energy. Collection is agentless and passive, extracting device context from known and unknown protocols. Its distinguishing technique is network traffic emulation: the platform builds virtual stand-ins for devices from their traffic and probes those instead of the live equipment, so vulnerability testing never touches a device in clinical use.
Source: AI Health Index, September 2026
Questions buyers ask
How do Claroty and Cylera work with the EHR?
The integrations catalog lists connectors built and supported by Claroty for Accruent, in both directions with more than 60 device attributes, Nuvolo on ServiceNow, TRIMEDX, ServiceNow, Splunk, CrowdStrike, Rapid7, Tenable, Cisco, Aruba ClearPass, Check Point, Fortinet and Palo Alto. Parkland Health runs a live connection to its CMMS and University of Rochester Medicine enforces firewall policy from xDome classifications.
With Cylera, integration pages and solution briefs cover Cisco ISE, Prime and DNA Center, Aruba ClearPass, Extreme NAC, Forescout, Illumio, Check Point, SonicWall, Microsoft Sentinel, Google Chronicle, IBM QRadar, Splunk, Rapid7 InsightVM, ServiceNow, Nuvolo and Integra e-Quip. No named hospital is shown running a two-way CMMS integration. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 30, 2026. No vendor pays for placement.
How do Claroty and Cylera handle patient data?
In Claroty's case, the HIPAA policy (effective 30 Sep 2024) says device traffic may incidentally contain PHI and bars de-identifying PHI for internal use without authorization.
For Cylera, the privacy statements cover website visitors only. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 30, 2026. No vendor pays for placement.
Which settings and specialties do Claroty and Cylera cover?
With Claroty, coverage outside hospitals, such as ambulatory or home care networks, is not described.
In Cylera's case, the platform covers medical devices, OT and IoT for hospitals and health networks in North America and Europe, with roles for biomedical engineering, IT and security, and it now also sells to finance, higher education, transportation, manufacturing and energy. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 30, 2026. No vendor pays for placement.
What evidence is published for Claroty and Cylera?
KLAS rated Claroty a 2026 Top Performer for Healthcare IoT Security at 92.5 from 35 organizations, a satisfaction measure rather than a detection result.
St. Luke's University Health Network's CISO is quoted, case studies are listed for RWJBarnabas Health, St. Luke's and Morecambe Bay (behind download forms), the American Hospital Association selected Cylera as a preferred cybersecurity provider in April 2021, and an analyst SPARK Matrix report is offered. The home page lists improvements in discovery, risk score accuracy and alert workload without a figure. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 30, 2026. No vendor pays for placement.
Both records were reviewed on this site in September 2026. Neither publishes a price. Claroty publishes ISO 27001 and 27701 certificates for download. Its HIPAA policy states business associate status. Cylera publishes no security attestation, product privacy terms, business associate position or hosting model. Neither publishes an approval step for its automation. Claire can apply segmentation policy and open tickets on its own. Claroty's terms leave human review to the customer. Cylera enrolls new devices into policy automatically. Claroty's AI Addendum lets it improve its products with data derived from customer environments. Claroty's customer results, such as 11,000 devices found at University of Rochester Medicine against 4,400 by its previous tool, are vendor published. Cylera's case studies sit behind download forms. Both publish rank claims about themselves, which this page does not rely on.
Ask Cylera how closely an emulated device matches the real one, and ask Claroty which Claire actions wait for approval.